FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3148376582> ?p ?o ?g. }

• W3148376582 endingPage "109465" @default.
• W3148376582 startingPage "109465" @default.
• W3148376582 abstract "Cervical cancer is the fourth common malignancy in women for which combinational therapy is the main treatment regimen. This study aimed to determine the effects of 60Co γ-ray high dose rate brachytherapy on the survival of HeLa cells with respect to X-ray of 6 MV linear accelerator (EBRT, external beam radiation therapy) as a comprehensive radiobiological concept. Furthermore, alterations in relative biological effectiveness (RBE) values were examined in combined treatments of cisplatin and radiation. Cell survival was evaluated following different treatments by clonogenic assay. The synergistic effects of cisplatin and X-ray were evaluated in terms of the combination index (CI). Moreover, fold change reduction of each treatment in combination therapy was determined by evaluating the dose reduction index (DRI). RBE values were also determined after different treatments. Maximum values of DRI for cisplatin and radiation were 128 and 2.2-fold reduction when used in combination, respectively. As a result of the CI and DRI values, pretreatment with 2 μg/ml cisplatin for 2 h was selected as the most effective concentration and time, and it was used in RBE evaluation. The RBE values at 50% cell survival after treatment with radiation alone and also combined with cisplatin were measured as 1.308 and 1.553, respectively. These RBE values indicate a more destructive effect of γ-radiation brachytherapy than X-ray EBRT. The results of combined treatment indicate a remarkable synergism. Furthermore, our data determined that 60Co γ-ray is more effective than EBRT X-ray to induce cell death in HeLa cells." @default.
• W3148376582 created "2021-04-13" @default.
• W3148376582 creator A5024926055 @default.
• W3148376582 creator A5033245990 @default.
• W3148376582 creator A5051377193 @default.
• W3148376582 creator A5055200148 @default.
• W3148376582 creator A5068203337 @default.
• W3148376582 creator A5079971300 @default.
• W3148376582 creator A5089802538 @default.
• W3148376582 date "2021-07-01" @default.
• W3148376582 modified "2023-10-03" @default.
• W3148376582 title "Assessing the relative biological effectiveness of high-dose rate 60Co brachytherapy alone and in combination with cisplatin treatment on a cervical cancer cell line (HeLa)" @default.
• W3148376582 cites W1483484436 @default.
• W3148376582 cites W1963650725 @default.
• W3148376582 cites W1963747692 @default.
• W3148376582 cites W1964867778 @default.
• W3148376582 cites W1975837000 @default.
• W3148376582 cites W1981067699 @default.
• W3148376582 cites W1982415526 @default.
• W3148376582 cites W1992199596 @default.
• W3148376582 cites W2005225437 @default.
• W3148376582 cites W2024938615 @default.
• W3148376582 cites W2025704513 @default.
• W3148376582 cites W2033995573 @default.
• W3148376582 cites W2055313293 @default.
• W3148376582 cites W2061881977 @default.
• W3148376582 cites W2071387709 @default.
• W3148376582 cites W2079417854 @default.
• W3148376582 cites W2080731049 @default.
• W3148376582 cites W2082390885 @default.
• W3148376582 cites W2084705984 @default.
• W3148376582 cites W2099245483 @default.
• W3148376582 cites W2103562758 @default.
• W3148376582 cites W2104631398 @default.
• W3148376582 cites W2123934092 @default.
• W3148376582 cites W2126052700 @default.
• W3148376582 cites W2131654458 @default.
• W3148376582 cites W2132834292 @default.
• W3148376582 cites W2157276711 @default.
• W3148376582 cites W2165767756 @default.
• W3148376582 cites W2585350393 @default.
• W3148376582 cites W2780250145 @default.
• W3148376582 cites W2915590029 @default.
• W3148376582 cites W2939095932 @default.
• W3148376582 cites W3003553766 @default.
• W3148376582 cites W4243284490 @default.
• W3148376582 doi "https://doi.org/10.1016/j.radphyschem.2021.109465" @default.
• W3148376582 hasPublicationYear "2021" @default.
• W3148376582 type Work @default.
• W3148376582 sameAs 3148376582 @default.
• W3148376582 citedByCount "1" @default.
• W3148376582 countsByYear W31483765822022 @default.
• W3148376582 crossrefType "journal-article" @default.
• W3148376582 hasAuthorship W3148376582A5024926055 @default.
• W3148376582 hasAuthorship W3148376582A5033245990 @default.
• W3148376582 hasAuthorship W3148376582A5051377193 @default.
• W3148376582 hasAuthorship W3148376582A5055200148 @default.
• W3148376582 hasAuthorship W3148376582A5068203337 @default.
• W3148376582 hasAuthorship W3148376582A5079971300 @default.
• W3148376582 hasAuthorship W3148376582A5089802538 @default.
• W3148376582 hasConcept C111337013 @default.
• W3148376582 hasConcept C117262875 @default.
• W3148376582 hasConcept C11928243 @default.
• W3148376582 hasConcept C121332964 @default.
• W3148376582 hasConcept C121608353 @default.
• W3148376582 hasConcept C125118446 @default.
• W3148376582 hasConcept C126322002 @default.
• W3148376582 hasConcept C126894567 @default.
• W3148376582 hasConcept C143998085 @default.
• W3148376582 hasConcept C1491633281 @default.
• W3148376582 hasConcept C185544564 @default.
• W3148376582 hasConcept C185592680 @default.
• W3148376582 hasConcept C206684579 @default.
• W3148376582 hasConcept C2776694085 @default.
• W3148376582 hasConcept C2777366897 @default.
• W3148376582 hasConcept C2777416452 @default.
• W3148376582 hasConcept C2778220009 @default.
• W3148376582 hasConcept C2778239845 @default.
• W3148376582 hasConcept C2989005 @default.
• W3148376582 hasConcept C502942594 @default.
• W3148376582 hasConcept C509974204 @default.
• W3148376582 hasConcept C55493867 @default.
• W3148376582 hasConcept C71924100 @default.
• W3148376582 hasConceptScore W3148376582C111337013 @default.
• W3148376582 hasConceptScore W3148376582C117262875 @default.
• W3148376582 hasConceptScore W3148376582C11928243 @default.
• W3148376582 hasConceptScore W3148376582C121332964 @default.
• W3148376582 hasConceptScore W3148376582C121608353 @default.
• W3148376582 hasConceptScore W3148376582C125118446 @default.
• W3148376582 hasConceptScore W3148376582C126322002 @default.
• W3148376582 hasConceptScore W3148376582C126894567 @default.
• W3148376582 hasConceptScore W3148376582C143998085 @default.
• W3148376582 hasConceptScore W3148376582C1491633281 @default.
• W3148376582 hasConceptScore W3148376582C185544564 @default.
• W3148376582 hasConceptScore W3148376582C185592680 @default.
• W3148376582 hasConceptScore W3148376582C206684579 @default.
• W3148376582 hasConceptScore W3148376582C2776694085 @default.
• W3148376582 hasConceptScore W3148376582C2777366897 @default.

• next